DeutschNewstral
Article
Fft.com on 2015-05-28 18:58
Teva pays $1.2bn in antitrust drugs case
Related news
Teva fined $1.2 billion in US antitrust casetimesofisrael.com- FAllergan sells generic drugs unit to Tevaft.com
Teva pays $1.2 billion to settle pay-for-delay allegationsabqjournal.com- EU antitrust authorities launch probe of Teva over Copaxone drugtimesofisrael.com
- Teva, IBM to tackle new drugs, chronic diseases with AItimesofisrael.com
Israel's Teva Rallies on Modest Settlement in Opioid CaseHaaretz- Teva settles with Oklahoma for $85 million in opioid casetimesofisrael.com
FTC discusses potential antitrust case against FacebookPOLITICO- Antitrust body probing Teva over distribution firmHaaretz
- HOklahoma, Teva Pharmaceuticals Reach $85 Million Settlement in Opioid Casehamodia.com
Oklahoma, Teva Pharmaceuticals reach $85 million settlement in opioid caseThe Day
EU antitrust regulators investigating Teva over its Copaxone drugThe Jerusalem Post (JPost.com)
Facebook asks recusal of FTC head in antitrust case decisionstaradvertiser.com- TAppeals court rejects states’ bid to revive Meta antitrust casethehill.com
Facebook moves to dismiss the US government’s antitrust caseThe Verge
Facebook Case Presents Test for Antitrust Enforcement, Federal Courtswsj.com
Teva to pay $1.2B for 'delays'Philly.com
U.S. antitrust case against Google a welcome startSeattle Times
California to join federal antitrust case against Googleseattletimes.com- NBreaking down Google antitrust casenews.harvard.edu